4-hydroxybenzaldehyde and 4-methylcatechol

4-hydroxybenzaldehyde has been researched along with 4-methylcatechol in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kapur, S; Rosario, M; Selassie, CD; Verma, RP	1
Bridewell, DJ; Ching, LM; Flanagan, JU; Fung, SP; Jamie, JF; Palmer, BD; Squire, CJ; Tijono, SM; Tomek, P; Wang, H	1

Other Studies

2 other study(ies) available for 4-hydroxybenzaldehyde and 4-methylcatechol

Article	Year
Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study. Journal of medicinal chemistry, 2005, Nov-17, Volume: 48, Issue:23 Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Mice; Molecular Conformation; Phenols; Quantitative Structure-Activity Relationship; Vinblastine	2005
Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1). Bioorganic & medicinal chemistry, 2013, Dec-15, Volume: 21, Issue:24 Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Hydrazines; Immune System; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship	2013

Article

Year

Cellular apoptosis and cytotoxicity of phenolic compounds: a quantitative structure-activity relationship study.

Journal of medicinal chemistry, 2005, Nov-17, Volume: 48, Issue:23

Topics: Animals; Antineoplastic Agents; Apoptosis; Caspases; Cell Line, Tumor; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Enzyme Activation; Mice; Molecular Conformation; Phenols; Quantitative Structure-Activity Relationship; Vinblastine

2005

Discovery and characterisation of hydrazines as inhibitors of the immune suppressive enzyme, indoleamine 2,3-dioxygenase 1 (IDO1).

Bioorganic & medicinal chemistry, 2013, Dec-15, Volume: 21, Issue:24

Topics: Animals; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Discovery; Enzyme Inhibitors; Humans; Hydrazines; Immune System; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Models, Molecular; Molecular Structure; Recombinant Proteins; Structure-Activity Relationship

2013